Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Takeshi, Kimura"'
Autor:
Yugo Yamashita, Takeshi Morimoto, Kazushige Kadota, Toru Takase, Seiichi Hiramori, Kitae Kim, Maki Oi, Masaharu Akao, Yohei Kobayashi, Mamoru Toyofuku, Moriaki Inoko, Tomohisa Tada, Po-Min Chen, Koichiro Murata, Yoshiaki Tsuyuki, Yuji Nishimoto, Jiro Sakamoto, Kiyonori Togi, Hiroshi Mabuchi, Kensuke Takabayashi, Takao Kato, Koh Ono, Takeshi Kimura
Publikováno v:
Scientific Reports. 12
There is a paucity of data on management strategies and clinical outcomes after recurrent venous thromboembolism (VTE). In a multicenter registry enrolling 3027 patients with acute symptomatic VTE, the current study population was divided into the fo
Publikováno v:
Scientific Reports. 12
Autor:
Tetsuma Kawaji, Satoshi Shizuta, Kyohei Yamaji, Munekazu Tanaka, Kazuki Kitano, Takanori Aizawa, Shintaro Yamagami, Akihiro Komasa, Takashi Yoshizawa, Masashi Kato, Takafumi Yokomatsu, Shinji Miki, Koh Ono, Takeshi Morimoto, Takeshi Kimura
Publikováno v:
Heart and Vessels. 37:1242-1254
It is still controversial whether catheter ablation for atrial fibrillation (AF) could improve clinical outcomes in general AF population. Among 4398 patients with diagnosis of AF in the outpatient department of Kyoto University Hospital between Janu
Autor:
Hiroki Watanabe, Shingo Hirao, Tatsuhiko Komiya, Naoki Kanemitsu, Jiro Esaki, Kenji Minatoya, Hiroyuki Hara, Takeshi Morimoto, Yuki Hori, Takeshi Kimura
Publikováno v:
General Thoracic and Cardiovascular Surgery. 70:419-429
We assessed the clinical effectiveness of coronary artery bypass grafting (CABG) in comparison with that of percutaneous coronary intervention (PCI) in octogenarians with triple-vessel disease (TVD) or left main coronary artery (LMCA) disease. From t
Autor:
Kazuki Matsushita, Kiyonori Togi, Tomohisa Tada, Yugo Yamashita, Seiichi Hiramori, Kazushige Kadota, Takeshi Morimoto, Yoshiaki Tsuyuki, Hidewo Amano, Mamoru Toyofuku, Yuta Tsujisaka, Syunsuke Saga, Hiroshi Mabuchi, Command Vte Registry Investigators, Yuji Nishimoto, Tomoki Sasa, Arata Sano, Masaharu Akao, Kosuke Doi, Minako Kinoshita, Kensuke Takabayashi, Fumiya Yoneda, Ryosuke Murai, Takeshi Kimura, Jiro Sakamoto, Maki Oi, Toshiaki Izumi, Kohei Osakada, Takao Kato, Kitae Kim, Yuta Seko, Toru Takase, Reo Hata, Yohei Kobayashi, Koh Ono, Po-Min Chen, Koichiro Murata
Publikováno v:
Journal of Thrombosis and Thrombolysis. 53:540-549
Anticoagulation therapy is prescribed for the prevention of recurrence in patients with venous thromboembolism, which could be temporarily interrupted during invasive procedures. The COMMAND VTE Registry is a multicenter registry enrolling 3027 conse
Autor:
Masashi, Sakuma, Satoshi, Iimuro, Tomohiro, Shinozaki, Takeshi, Kimura, Yoshihisa, Nakagawa, Yukio, Ozaki, Hiroshi, Iwata, Katsumi, Miyauchi, Hiroyuki, Daida, Satoru, Suwa, Ichiro, Sakuma, Yosuke, Nishihata, Yasushi, Saito, Hisao, Ogawa, Masunori, Matsuzaki, Yasuo, Ohashi, Isao, Taguchi, Shigeru, Toyoda, Teruo, Inoue, Ryozo, Nagai
Publikováno v:
BMC Medicine. 20
Background Aggressive lipid lowering by high-dose statin treatment has been established for the secondary prevention of coronary artery disease (CAD). Regarding the low-density lipoprotein cholesterol (LDL-C) level, however, the “The lower is the b
Autor:
Yugo Yamashita, Kensuke Takabayashi, Kazushige Kadota, Takeshi Morimoto, Masaharu Akao, Yoshiaki Tsuyuki, Koh Ono, Mamoru Toyofuku, Seiichi Hiramori, Hidewo Amano, Takao Kato, Yuji Nishimoto, Moriaki Inoko, Koichiro Murata, Po-Min Chen, Maki Oi, Kohei Osakada, Kazuki Matsushita, Kiyonori Togi, Tomohisa Tada, Yohei Kobayashi, Reo Hata, Tomoki Sasa, Arata Sano, Toru Takase, Command Vte Registry Investigators, Kitae Kim, Minako Kinoshita, Jiro Sakamoto, Hiroshi Mabuchi, Takeshi Kimura
Publikováno v:
Journal of Thrombosis and Thrombolysis. 53:182-190
Prolonged anticoagulation therapy is recommended for patients with intermediate-risk for recurrence of venous thromboembolism (VTE). The current study aimed to identify risk factors of VTE recurrence and major bleeding in intermediate-risk patients.
Autor:
Tetsuma Kawaji, Satoshi Shizuta, Kyohei Yamaji, Munekazu Tanaka, Kazuki Kitano, Takanori Aizawa, Shintaro Yamagami, Akihiro Komasa, Takashi Yoshizawa, Masashi Kato, Takafumi Yokomatsu, Shinji Miki, Koh Ono, Takeshi Morimoto, Takeshi Kimura
Publikováno v:
Heart and Vessels. 38:879-880
Autor:
Yugo Yamashita, Koh Ono, Seiichi Hiramori, Maki Oi, Takao Kato, Yoshiaki Tsuyuki, Mamoru Toyofuku, Po-Min Chen, Takeru Makiyama, Yusuke Morita, Syunsuke Saga, Yuji Nishimoto, Takeshi Morimoto, Hiroshi Mabuchi, Masaharu Akao, Yohei Kobayashi, Koichiro Murata, Kensuke Takabayashi, Takeshi Kimura, Yusuke Yoshikawa, Kiyonori Togi, Tomohisa Tada, Toshiaki Izumi, Tomoki Sasa, Kitae Kim, Command Vte Registry Investigators, Minako Kinoshita, Jiro Sakamoto, Hiroki Shiomi, Toru Takase, Hidewo Amano
Publikováno v:
Journal of Thrombosis and Thrombolysis. 51:779-788
There are uncertainties on the influence of the days of diagnosis in a week (weekends versus weekdays) on clinical outcomes in patients with acute venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT). The COM
Autor:
Mamoru Toyofuku, Yutaka Hirano, Tomohiko Taniguchi, Hirokazu Mitsuoka, Katsuhisa Ishii, Koichiro Murata, Shinichi Shirai, Kozo Hotta, Hiroki Shiomi, Hiroshi Mabuchi, Norio Kanamori, Yoshihiro Kato, Makoto Miyake, Kenji Minatoya, Tomoyuki Ikeda, Naritatsu Saito, Tsukasa Inada, Takeshi Morimoto, Kazuhiro Yamazaki, Current As Registry Investigators, Shintaro Matsuda, Yuichi Kawase, Keiichiro Yamane, Yasuaki Takeji, Takeshi Kitai, Toshikazu Jinnai, Masashi Kato, Kazuya Nagao, Chisato Izumi, Mitsuru Ishii, Nobuya Higashitani, Eri Minamino-Muta, Moriaki Inoko, Yuko Morikami, Takeshi Kimura, Yasuyo Takeuchi, Yasutaka Inuzuka, Kenji Ando
Publikováno v:
Cardiovascular Intervention and Therapeutics. 36:121-130
Two randomized control trials demonstrated that transcatheter aortic valve implantation was associated with 1–2 year clinical outcomes comparable or even superior to surgical aortic valve replacement (SAVR) in low surgical risk patients with severe